Publisher
Springer International Publishing
Reference59 articles.
1. Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, et al. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. J Endocrinol Investig. 2005;28(11 Suppl International):111–7.
2. Ntali G, Wass JA. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary. 2018;21(2):111–8.
3. Molitch ME. Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab. 2009;23(5):667–75.
4. Ho DM, Hsu CY, Ting LT, Chiang H. The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. Hum Pathol. 1997;28(8):905–11.
5. Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. 2017;28(3):228–43.